SCHEMBL3580179

SCHEMBL3580179

CC12CCC(CC1C(=O)O)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 2/20 0.38
SLC1A1 P43005 2/20 0.38
APLNR P35414 1/20 0.35
LMNA P02545 3/20 0.33
GRM2 Q14416 2/20 0.33
GRM3 Q14832 2/20 0.33
GRM4 Q14833 2/20 0.33
CYP1A2 P05177 2/20 0.33
ALOX15 P16050 2/20 0.33
CYP2C19 P33261 2/20 0.33
TSHR P16473 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
GRM8 O00222 1/20 0.33
GRM6 O15303 1/20 0.33
GRM5 P41594 1/20 0.33
MTOR P42345 1/20 0.33
GRM1 Q13255 1/20 0.33
PLCB1 Q9NQ66 1/20 0.33
HSD11B1 P28845 2/20 0.33
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25929681 0.88 SLC1A2 (0.40) SLC1A2SLC1A1APLNRLMNAGRM2
SCHEMBL9011285 0.84 G6PD (0.30)
SCHEMBL11063629 0.79 ATM (0.37) CYP1A2CYP2C19TSHRPOLB
SCHEMBL9141620 0.73 GRM4 (0.34) SLC1A2SLC1A1LMNAGRM2GRM3
SCHEMBL22941787 0.73 GRM4 (0.34) SLC1A2SLC1A1LMNAGRM2GRM3
SCHEMBL1151609 0.73 APLNR (0.34) SLC1A2SLC1A1APLNRHSD11B1
SCHEMBL5925394 0.72 GRM2 (0.33) SLC1A2SLC1A1LMNAGRM2GRM3
SCHEMBL15440623 0.72 GRM4 (0.37) SLC1A2SLC1A1LMNAGRM2GRM3
SCHEMBL7079218 0.72 GRM2 (0.33) SLC1A2SLC1A1LMNAGRM2GRM3
SCHEMBL76019 0.72 GRM4 (0.37) SLC1A2SLC1A1LMNAGRM2GRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2977373-B1 METHOD FOR THE CATALYTIC PRODUCTION OF ESTERS EVONIK DEGUSSA GMBH (DE) 2017-10-25 EP disclosed
US-9605001-B2 Production of polyketides and other natural products BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2017-03-28 US disclosed
EP-3030544-A1 METHOD FOR THE SYNTHESIS OF SATURATED CARBOXYLIC ACID ESTERS Evonik Degussa GmbH (DE) 2016-06-15 EP disclosed
EP-2977373-A1 METHOD FOR THE CATALYTIC PRODUCTION OF ESTERS Evonik Degussa GmbH (DE) 2016-01-27 EP disclosed
US-20150266896-A1 PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS BIOTICA TECH LTD (GB) 2015-09-24 US disclosed
EP-1521828-B1 PRODUCTION OF POLYKETIDES BUCK INST FOR RES ON AGING (US) 2015-07-01 EP disclosed
WO-2015018845-A1 METHOD FOR THE SYNTHESIS OF SATURATED CARBOXYLIC ACID ESTERS LEIBNIZ-INSTITUT FÜR KATALYSE E.V. AN DER UNIVERSITÄT ROSTOCK (DE) 2015-02-12 WO disclosed
US-7645768-B2 Production of polyketides and other natural products WYETH (US) 2010-01-12 US disclosed
CN-100569944-C Production of polyketides and other natural products BIOTICA TECH LTD (GB) 2009-12-16 CN disclosed
US-20080287482-A1 Production of Polyketides and Other Natural Products GREGORY MATTHEW ALAN 2008-11-20 US disclosed
CN-101302225-A Production of polyketides and other natural products BIOTICA TECH LTD (GB) 2008-11-12 CN disclosed
EP-1967520-A2 Production of polyketides and other natural products Biotica Technology Limited (GB) 2008-09-10 EP disclosed
US-7390895-B2 Production of polyketides and other natural products BIOTICA TECHNOLOGY LIMITED (GB) 2008-06-24 US disclosed
US-20080039486-A1 PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS GREGORY MATTHEW A 2008-02-14 US disclosed
US-20080021211-A1 PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS BIOTICA TECHNOLOGY LIMITED (GB) 2008-01-24 US disclosed
EP-1589031-B1 Production of polyketides and other natural products BIOTICA TECH LTD (GB) 2007-08-15 EP disclosed
EP-1655372-A2 Production of polyketides and other natural products Biotica Technology Limited (GB) 2006-05-10 EP disclosed
US-20060078980-A1 Production of polyketides and other natural products GREGORY MATTHEW A 2006-04-13 US disclosed
EP-1589031-A2 Production of polyketides and other natural products Biotica Technology Limited (GB) 2005-10-26 EP disclosed
CN-1668741-A Production of polyketides and other natural products BIOTICA TECH LTD (GB) 2005-09-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266896-A1 PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS FKBP14, FKBP4, FKBP2 SLC1A2 4426/4885SLC1A1 4237/4885APLNR 1899/4885
US-20080021211-A1 PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS FKBP14, FKBP4, FKBP2 SLC1A2 4426/4885SLC1A1 4237/4885APLNR 1899/4885
US-20080287482-A1 Production of Polyketides and Other Natural Products FKBP14, FKBP4, FKBP2 SLC1A2 4426/4885SLC1A1 4237/4885APLNR 1899/4885
US-20080039486-A1 PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS FKBP14, FKBP4, FKBP2 SLC1A2 4426/4885SLC1A1 4237/4885APLNR 1899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.